DIPG-65. Novel patient-based pharmacokinetic drug screening reveals gemcitabine potential in pediatric H3K27-altered diffuse midline gliomas

Author(s):: Scheffers, L.M.; Bianco, J.; Su, Y.; Ringnalda, F.C.A.; Lange, E.C.M. de (0000-0001-8303-1117); Huitema, A.D.R.; Vuurden, D.G. van

Published: 2024
Publication type: Article / Letter to editor

Date issued: 2024-06-18
Language: English
Publisher: Oxford University Press (OUP)
Is part of: Neuro-Oncology (2024), No. Supplement 4, NOAE064118
hdl: 1887/4106948
doi: 10.1093/neuonc/noae064.118
URL: https://academic.oup.com/neuro-oncology/article/26/Supplement_4/0/7694392#google_vignette